Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Kynurenine Pathway in Aut… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kynurenine Pathway in Autism Spectrum Disorders in Children

Artikel i vetenskaplig tidskrift
Författare V. Bryn
R. Verkerk
Ola H. Skjeldal
O. D. Saugstad
H. Ormstad
Publicerad i Neuropsychobiology
Volym 76
Nummer/häfte 2
Sidor 82-88
ISSN 0302-282X
Publiceringsår 2018
Publicerad vid Gillbergcentrum
Sidor 82-88
Språk en
Länkar dx.doi.org/10.1159/000488157
Ämnesord Autism spectrum disorders, Kynurenine pathway, Kynurenic acid, Tryptophan, major depressive disorder, amino-acid receptors, quinolinic acid, tryptophan catabolites, brain tryptophan, metabolism, inflammation, disease, plasma, serum, Neurosciences & Neurology, Psychiatry, Psychology, one tw, 1993, pharmacological reviews, v45, p309, one tw, 1981, european journal of pharmacology, v72, p411
Ämneskategorier Neurobiologi

Sammanfattning

Background: There is increasing evidence that altered immune responses play a role in the pathogenesis of autism spectrum disorders (ASD), together with dysfunction of the serotonergic and glutamatergic systems. Since the kynurenine (KYN) pathway that degrades tryptophan (TRP) is activated in various neuroinflammatory states, we aimed to determine whether this pathway is activated in ASD. Methods: Sixty-five pediatric ASD patients (including 52 boys) were enrolled from an epidemiological survey covering 2 counties in Norway; 30 (46.5%) of these patients were diagnosed with childhood autism, 16 (24.6%) with Asperger syndrome, 12 (18.5%) with atypical autism, 1 (1.5%) with Rett syndrome, and 6 (9.2%) with other ASD. The serum levels of the following markers were measured in the children with ASD and compared to those in 30 healthy children: TRP, KYN, kynurenic acid (KA), 3-hydroxykynurenine, and quinolinic acid. Results: The mean serum level of KA was significantly lower in the ASD group than in the healthy controls (28.97 vs. 34.44 nM, p = 0.040), while the KYN/KA ratio was significantly higher in the ASD group (61.12 vs. 50.39, p = 0.006). The same relative values were found when comparing the childhood autism subgroup with the controls. Also, the mean serum level of TRP was significantly lower in children with a subdiagnosis of childhood autism than in those with Asperger syndrome (67.26 vs. 77.79 mu m, p = 0.020). Conclusion: Our study indicates that there is an increased neurotoxic potential and also a possible lower KYN aminotransferase activity in ASD. (C) 2018 S. Karger AG, Basel

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://www.gu.se/forskning/publikation/?tipFriend=true&tipUrl=http%3A%2F%2Fwww.gu.se%2Fforskning%2Fpublikation%2F%3Fprint%3Dtrue%26publicationId%3D268988&publicationId=268988
Utskriftsdatum: 2019-09-23